Literature DB >> 1975341

Established anticonvulsants and treatment of refractory epilepsy.

M J Brodie1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975341     DOI: 10.1016/0140-6736(90)91886-f

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

1.  Primary Generalized Epilepsies.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-11       Impact factor: 3.598

Review 2.  Neurology.

Authors:  A N Gale; J M Gibbs; A H Schapira; P K Thomas
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

3.  Synthesis, anticonvulsant and neurotoxicity evaluation of some new pyrimidine-5-carbonitrile derivatives.

Authors:  Mohammad Shaquiquzzaman; Suroor Ahmad Khan; Mohammad Amir; Mohammad Mumtaz Alam
Journal:  Saudi Pharm J       Date:  2011-09-24       Impact factor: 4.330

Review 4.  Clinical management of brain metastasis.

Authors:  C J Vecht
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

Review 5.  Pharmacokinetic changes during pregnancy and their clinical relevance.

Authors:  R Loebstein; A Lalkin; G Koren
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 6.  Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.

Authors:  Katharine J Palmer; Donna McTavish
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

7.  Monotherapy with conventional and controlled-release carbamazepine: a double-blind, double-dummy comparison in epileptic patients.

Authors:  P J McKee; J Blacklaw; E Butler; R A Gillham; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

Review 8.  Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.

Authors:  S M Grant; D Faulds
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

Review 9.  Pharmacokinetic optimisation of anticonvulsant therapy.

Authors:  A H Thomson; M J Brodie
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

Review 10.  Antiepileptic drugs. A review of clinically significant drug interactions.

Authors:  P N Patsalos; J S Duncan
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.